Press Releases

Date Title and Summary Additional Formats
Toggle Summary Evoke Pharma Announces Pricing of Initial Public Offering of 2,100,000 Shares of Common Stock
SAN DIEGO, CA, September 24, 2013 – Evoke Pharma, Inc., a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced the pricing of its initial public offering of 2,100,000 shares of its common stock at a public offering price of $12.00 per
View HTML